RHN van Schaik
Erasmus MC(NL)International Pharmaceutical Federation(NL)Erasmus University Rotterdam(NL)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Renal Transplantation Outcomes and Treatments, Pharmacological Effects and Toxicity Studies, Pharmaceutical studies and practices, Blood Pressure and Hypertension Studies
Most-Cited Works
- → Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing(2015)668 cited
- → Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting(2015)178 cited
- → Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β-Blocker Users(2008)144 cited
- → Cytochrome P450 2C9 *2 and *3 Polymorphisms and the Dose and Effect of Sulfonylurea in Type II Diabetes Mellitus(2007)118 cited
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing(2015)
- → The 5-HT1A receptor C(1019)G polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation(2014)50 cited
- → Genotypes Associated With Reduced Activity of VKORC1 and CYP2C9 and Their Modification of Acenocoumarol Anticoagulation During the Initial Treatment Period